Differences in Antioxidant and Lipid Handling Protein Expression Influence How Cells Expressing Distinct Mutant TP53...

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• The TP53 tumor suppressor gene is frequently mutated in human cancers.
• Iron is essential for cancer cell growth and proliferation.
• The interplay between TP53 mutations and iron metabolism in cancer remains poorly understood.

Purpose of the Study:

• To investigate how different TP53 mutation subtypes influence cellular responses to iron restriction.
• To identify molecular mechanisms underlying TP53 mutation-specific sensitivities to iron availability.

Main Methods:

• Generated eight isogenic cell lines with varying TP53 statuses (null, wild-type, six common hotspot mutations).
• Utilized isobaric peptide labeling and mass spectrometry for quantitative proteomic analysis.
• Assessed protein expression changes in response to mutant TP53 induction and iron chelation.

Main Results:

• Sensitivity of cancer cells to iron restriction varies significantly based on TP53 mutation subtype.
• These sensitivities are primarily linked to alterations in antioxidant and lipid handling proteins, not direct responses to iron chelation.
• Identified unique TP53-dependent protein expression profiles under iron-restricted conditions.

Conclusions:

• Distinguishing between TP53 mutation subtypes is crucial for understanding their role in cancer iron metabolism.
• Targeting mutant TP53 requires considering specific mutation profiles and their impact on cellular pathways.
• Exploiting identified TP53-dependent protein expression changes could enhance iron-targeted cancer therapies.